Mednet is now part of the Launchit Ventures Group. Learn more >

Mednet Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

RESOURCE LINE

VACCINE

Spring 2012

NACI: New recommendations for the quadrivalent HPV vaccine for malesNational Advisory Committee on Immunization. Canada Communicable Disease Report January 2012;38:ACS-7. Recommendations for the use of the quadrivalent human papillomavirus...

PRIORITY PRESS - CACMID-AMMI Canada 2012 Annual Conference

Invasive Fungal Infections in Severely Immunocompromised Patients: Strategies to Improve Overall Survival

Vancouver, British Columbia / May 3-5, 2012

Vancouver - Invasive fungal infections (IFIs) affect mainly patients with hematological malignancies undergoing hematopoietic stem cell transplantation. Invasive aspergillosis (IA) accounts for the majority of these infections and it can be...

PRIORITY PRESS - 22nd European Congress on Clinical Microbiology and Infectious Diseases (ECCMID)

Primary Treatment of Invasive Aspergillosis in Hematology Patients

London, UK / March 31- April 3, 2012

London - The first randomized study of combination therapy in the treatment of invasive aspergillosis (IA) has provided new evidence-based guidance for hematological malignancy patients, including allograft hematopoietic stem cell...

PRIORITY PRESS - 22nd Scientific Meeting of the European Society of Hypertension

Optimizing Hypertension Treatment to Improve Renal Outcomes in Patients with Diabetes

London, UK / April 26-29, 2012

London - The first-line antihypertensive agent in patients with diabetes and either one additional cardiovascular (CV) risk factor, evidence of renal dysfunction, such as microalbuminuria, or both, is an ACE inhibitor or an angiotensin...

PRIORITY PRESS - Annual Meeting of the Canadian Society of Nephrology

Thrombotic Microangiopathies: Focus on Atypical Hemolytic-uremic Syndrome

St. John’s, Newfoundland and Labrador / April 25-30, 2012

St. John’s - Thrombotic microangiopathies are microvascular occlusive disorders characterized by systemic aggregation of platelets, thrombocytopenia and mechanical injury to red blood cells. In the more common hemolytic uremic...

MEDICAL FRONTIERS - 6th International Conference on Thrombosis and Hemostasis Issues in Cancer

Treatment and Prevention of Venous Thrombosis in Cancer

Bergamo, Italy / April 20-22, 2012

Bergamo - Cancer is a hypercoagulable state where malignancy heightens thrombotic risk throughout the course of active disease, especially during metastases. Anti-angiogenic chemotherapy agents can significantly increase embolic risk, as...

PHYSICIAN PERSPECTIVE - Viewpoint based on the following articles: Santolaya et al. Lancet 2012;379:617-24, Gossger et al. JAMA 2012;307(6):573-82.

Closing the Gap on N. meningitidis: Potential for Imminent Disease Control

April 2012

Guest Editor:  Ronald Gold, MD, MPHFormer Head, Division of Infectious DiseaseThe Hospital for Sick ChildrenToronto, OntarioProfessor of Pediatrics (Retired) Faculty of Medicine, University of TorontoMedical AdvisorMeningitis Research...

PRIORITY PRESS - 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Real-world Clinical Experience Treating Gram-positive Infections

London, UK / March 31-April 3, 2012

London - Several new sets of data were presented at ECCMID that provided guidance on the efficacy of some of the most effective antibiotics for the treatment of serious Gram-positive infections. One of these was the ongoing European...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the Annual Meeting of the Canadian Rheumatology Association

The Role of Biologics in Psoriatic Arthritis Disease Control

Victoria, British Columbia / March 28-31, 2012

Reviewed and edited by: Majed M. Khraishi, MB, BSc, FRCPCMedical Director (Rheumatology)Nexus Clinical ResearchClinical Professor of Medicine (Rheumatology)Memorial University of NewfoundlandSt. John’s, Newfoundland &...

MEDICAL FRONTIERS - XVI International Symposium on Atherosclerosis

Cardiovascular Disease to Diabetes Prevention: The Potential of CETP Inhibition and Modulation

Sydney, Australia / March 25-29, 2012

Sydney - It is generally accepted that for every 0.1 mmol/L increase in HDL-C, there is an associated coronary artery disease risk reduction of ~10%. While raising HDL-C levels reduces the risk of atherosclerosis, a more specific focus on...

PAGE 21 OF 110   ... 21 22 23 24 25 26 27 28 29 30 ...
All Rights Reserved - Mednet Inc.
Launchit Ventures
Mednet Inc. is part of the Launchit Ventures Group